George Pappas

George F. Pappas

Download V-card

Covington & Burling LLP
One CityCenter
850 Tenth Street, NW
Washington, DC 20001-4956
Tel: +1 202 662 5594
Fax: +1 202 778 5594



  • University of Maryland School of Law, J.D., 1975
    • Moot Court Board, Member
    • Jessup International Moot Court Team, Member
    • International Trade Law Journal, Founding Editor-in-Chief
  • University of Maryland, B.A., 1972
    • highest honors
    • Phi Beta Kappa

Bar Admissions

  • District of Columbia
  • Maryland

Clients wrestling with complex or bet-the-business intellectual property and commercial litigation turn to George Pappas.  Ranked in the top tier of lawyers for Intellectual Property by Chambers USA, clients have described Mr. Pappas as, "a class apart", "has tremendous presence in the courtroom and understands the legal issues very well.  He is both thorough and unrelenting.”  His peers have commented that, “He is a fantastic lead trial lawyer and, though very tough to compete against, is a true gentleman."

Representative Matters

Hatch-Waxman & Pharmaceutical 

  • Representation of UCB in the District of Delaware in patent litigation brought against Watson Laboratories, Inc. concerning Neupro® rotigotine transdermal system, used to treat the signs and symptoms of idiopathic Parkinson's disease and moderate-to-severe Restless Legs Syndrome.
  • Representation of Merck & Co., Inc. and Roche Palo Alto LLC in patent litigation in the District of New Jersey against Sun Pharmaceutical Industries, Ltd. relating to Ganirelix Acetate Injection, which is one of the drugs used in women undergoing in vitro fertilization.
  • Representation of UCB in Hatch-Waxman litigation filed against 16 generic companies in the District of Delaware involving UCB’s Vimpat® product, used in the treatment of epilepsy and other CNS disorders.
  • Representation of AstraZeneca in Hatch-Waxman patent litigation against Barr and Mylan concerning Entocort® EC, used for the treatment of Crohn’s disease.  AstraZeneca LP v. Mylan Pharmaceuticals, Inc (D. Del.).
  • Representation of Bristol-Myers Squibb in patent litigation in the District of New Jersey against Dr. Reddy’s Laboratories relating to IXEMPRA® Kit, an intravenous infusion treatment for metastatic or locally advanced breast cancer after failure of at least an anthracycline and a taxane.  Bristol-Myers Squibb Company v. Dr. Reddy’s Laboratories Ltd., et al. (D.N.J.).

Honors and Rankings

  • Fellow, American College of Trial Lawyers
  • Chairman, Complex Litigation Committee of the American College of Trial Lawyers
  • Listed as one of The Best Lawyers in America in Bet-the-Company Litigation, Commercial Litigation, and Intellectual Property Law (2006-2016)
  • Listed in Chambers USA (2006-2015) and Chambers Global (2007-2015) as a leading attorney in the area of Intellectual Property
  • The International Who's Who of Life Sciences Lawyers (2012)
  • IAM Patent 1000 - The World’s Leading Patent Practitioners (2015)
  • Who's Who Legal, Patents (2012-2013)
  • Legal 500 US, Intellectual Property: Patent Litigation (2012-2015); Trade Secrets: Litigation (2014-2015); Healthcare: Life Sciences (2015) and Litigation: Supreme Court & Appellate (2013)
  • Top 100 Washington D.C. Area Super Lawyers (2013-2015)
  • Washington DC Super Lawyers, Intellectual Property Litigation (2007-2015)
  • LMG Life Sciences Awards, shortlisted for Hatch-Waxman (Branded) Litigator of the Year (2013)
  • LMG Life Sciences, "Life Science Star" (2013)
  • Benchmark Litigation, National Star (2013-2014)
  • Washingtonian, Intellectual Property "Top Lawyer" (2013)
  • Named "The Top Business Litigator in DC" by Legal Times (2007)

Memberships and Affiliations

  • The American Law Institute, Member (2002-Present)
  • Consultative Group, Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes for The American Law Institute, Member
  • Appointed by Chief Judge Garrett E. Brown, Jr. to serve as a Member of the District of New Jersey Local Patent Rules Committee
  • Appointed by Chief Justice Rehnquist of the U.S. Supreme Court to serve as a Member of the District Judge Education Advisory Committee for the Federal Judicial Center (2001, 2004-2007)
  • U.S. District Court of Delaware Judges’ Intellectual Property Advisory Committee, 1998, 2001, 2003-Present (invited by active Federal Judges of the Court), Member
  • U.S. District Court of Delaware Electronic Discovery Committee, Member (2003-2006)
  • ALI-ABA Advisory Group on Intellectual Property, Member (2004-Present)
  • Maryland Statewide Business/Technology Case Management Advisory Committee, Member (2004-Present)
  • Chairman, Governor’s Commission on Development of Advanced Technology Business (“Pappas Commission”) (2002 - 2004)
  • Board of Visitors of the University of Maryland School of Law, Member (2000-Present)
  • University of Maryland School of Law IP Program Advisory Board, Member, (2002-Present)

Publications and Speeches

Mr. Pappas is Editor and Co-Author of the book, Anatomy of a Patent Case (2009; 2012 2nd ed.), which is prepared by the Complex Litigation Committee of the American College of Trial Lawyers.  He also is on the Practitioner and Academic Advisory Board of the Patent Case Management Judicial Guide (2009). 
  • "Obviousness & the Role of Secondary Considerations in Deciding Obviousness," International Judges Conference on Intellectual Property Law (5/23/2011)
  • "Patent Local Rules and Pre-Trial Orders Roundtable: Philosophy, Context, Logic and Departures” and “Dealing with Complex Technology: Tutorials and Educating the Court about Technology," Moderator at the Berkeley Center for Law & Technology, Federal Judicial Center Advanced Patent Program (September 2010)
  • "Patentable Subject Matter Under U.S. Patent Law," 24th Annual IPSANZ Conference (September 2010)
Print PDF Word Version Print this page